Skip to main content
Year archive

CONNEQT HEALTH LIMITED — 2016 filings

All 40 regulatory filings released by CONNEQT HEALTH LIMITED (CQT) in 2016, sourced directly from the official regulator.

40 Filings
2016 Period
2016 filings (40)
Filing Released Lang
Appendix 3B 8 pages 153.3KB
Share Issue/Capital Change
2016-12-22 English
Change of Director's Interest Notice x 3 6 pages 187.3KB
Director's Dealing
2016-12-22 English
Results of Meeting 1 page 90.9KB
Declaration of Voting Results & Voting Rights Announcements
2016-12-20 English
Appendix 3B 8 pages 153.7KB
Capital/Financing Update
2016-11-21 English
Cleansing Notice 1 page 142.1KB
Capital/Financing Update
2016-11-21 English
Notice of General Meeting/Proxy Form 9 pages 278.1KB
Proxy Solicitation & Information Statement
2016-11-17 English
AtCor completes share placement 2 pages 82.3KB
Capital/Financing Update
2016-11-15 English
Trading Halt 2 pages 224.8KB
Capital/Financing Update
2016-11-13 English
Leading research team highlights role of SphygmoCor 2 pages 110.9KB
Regulatory Filings
2016-11-03 English
Chairmans address to AGM 3 pages 97.6KB
Management Reports
2016-10-27 English
Results of Meeting 1 page 86.9KB
Declaration of Voting Results & Voting Rights Announcements
2016-10-27 English
Investor presentation 34 pages 833.6KB
Investor Presentation
2016-10-24 English
Appendix 3B - option exercise 8 pages 153.3KB
Capital/Financing Update
2016-10-23 English
Change of Director's Interest Notice 2 pages 151.2KB
Director's Dealing
2016-10-23 English
AtCor wins Frost & Sullivan's 2016 Diagnostic Devices award 1
Regulatory Filings
2016-10-17 English
AtCor launches key opinion leader webinar series 2 pages 113.1KB
Regulatory Filings
2016-09-25 English
Annual Report to shareholders 56 pages 11.3MB
Annual Report FY 2016
2016-09-25 English
Notice of Annual General Meeting/Proxy Form 6 pages 209.9KB
AGM Information
2016-09-25 English
Appendix 4G/Corporate Governance statement 19 pages 262.5KB
Governance Information
2016-09-25 English
Full Year Statutory Accounts 58 pages 594.3KB
Annual Report FY 2016
2016-08-29 English
FY2016 results 2 pages 132.0KB
Annual Report FY 2016
2016-08-29 English
CEO presentation to BioShares Conference 15 pages 380.4KB
Investor Presentation
2016-07-28 English
Appendix 3B 8 pages 153.1KB
Share Issue/Capital Change
2016-07-20 English
Large national plan to reimburse SphygmoCor test 1
Regulatory Filings
2016-07-06 English
$0.6 million pharmaceutical trial extension 1 page
Capital/Financing Update
2016-06-28 English
Appendix 3B 8 pages 138.4KB
Share Issue/Capital Change
2016-06-20 English
Change of Director's Interest Notice 2 pages 74.1KB
Director's Dealing
2016-06-20 English
Investor Presentation 26 pages 819.0KB
Investor Presentation
2016-05-01 English
Tax refund 1 page 26.9KB
Regulatory Filings
2016-03-13 English
Patent granted in USA 1 page 39.1KB
Regulatory Filings
2016-03-08 English
FDA clearance for Oscar 2 with SphygmoCor inside 2 pages 53.3KB
Regulatory Filings
2016-03-02 English
CPT-1 Reimbursement Update 2 pages 41.7KB
Capital/Financing Update
2016-02-28 English
Patent granted in Japan 1 page 39.1KB
Regulatory Filings
2016-02-16 English
Appendix 3B 8 pages 138.2KB
Share Issue/Capital Change
2016-02-16 English
Half Yearly Report and Accounts 18 pages 294.1KB
Interim / Quarterly Report H1 2016
2016-02-11 English
Appendix 3B 8 pages 138.3KB
Share Issue/Capital Change
2016-02-10 English
US$0.6m new pharmaceutical trial contract 2 pages 41.5KB
Capital/Financing Update
2016-02-04 English
Appendix 3B 8 pages 138.5KB
Share Issue/Capital Change
2016-02-01 English
Appendix 3B 8 pages 138.7KB
Capital/Financing Update
2016-01-21 English
Market update 2 pages 31.8KB
Earnings Release H1 2016
2016-01-07 English